Page last updated: 2024-11-02

pioglitazone and Small Cell Lung Carcinoma

pioglitazone has been researched along with Small Cell Lung Carcinoma in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Small Cell Lung Carcinoma: A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).

Research Excerpts

ExcerptRelevanceReference
"small vs."1.38Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer. ( Behrens, C; Bookout, AL; Gadzar, AF; Girard, L; Jeong, Y; Lee, W; Mangelsdorf, DJ; Minna, JD; Raso, G; Wistuba, II; Xie, Y, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, Y1
Xie, Y1
Lee, W1
Bookout, AL1
Girard, L1
Raso, G1
Behrens, C1
Wistuba, II1
Gadzar, AF1
Minna, JD1
Mangelsdorf, DJ1

Other Studies

1 other study available for pioglitazone and Small Cell Lung Carcinoma

ArticleYear
Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer.
    Molecular endocrinology (Baltimore, Md.), 2012, Volume: 26, Issue:8

    Topics: Analysis of Variance; Animals; Antineoplastic Agents; Area Under Curve; Biomarkers, Tumor; Carcinoma

2012